(File Photo: Source for Photo: This image provided by Eli Lilly shows the company’s new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday, July 2, 2024 for mild or early cases of dementia caused by Alzheimer’s. (Eli Lilly and Company via AP)

Noah Haswell, Beaver County Radio News

(Harrisburg, PA) This week, Democratic State Representative Emily Kinkead is planning to introduce a bill that would create the “Prescription Drug Copay Fairness Act” to crack down on the prices of prescription drugs in Pennsylvania. More people are getting sicker as the costs of prescription drugs continue to rise. According to Kinkead, the problem is regarding insurers’ “copay accumulator” policies, and she also added that insurance companies are not counting these payments from manufacturer assistance programs towards patients’ overall deductibles.